Citius Pharmaceuticals, Inc.
CTXR
$0.56
-$0.03-5.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.59M | 7.72M | 4.25M | 6.09M | 26.40K |
| Total Receivables | 1.08M | 4.05M | -- | -- | -- |
| Inventory | 22.66M | 22.64M | 22.29M | 17.21M | 15.34M |
| Prepaid Expenses | 3.36M | 3.54M | 1.40M | 1.31M | 3.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 31.69M | 37.95M | 27.93M | 24.61M | 18.37M |
|
|
|||||
| Total Current Assets | 31.69M | 37.95M | 27.93M | 24.61M | 18.37M |
| Net Property, Plant & Equipment | 794.50K | 835.20K | 818.70K | 880.70K | 922.10K |
| Long-term Investments | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Total Other Intangibles | 90.51M | 92.23M | 92.80M | 92.80M | 92.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 207.30K | 38.10K | 38.10K | 38.10K | 38.10K |
| Total Assets | 132.54M | 140.39M | 130.94M | 127.68M | 121.48M |
|
|
|||||
| Total Accounts Payable | 9.45M | 11.02M | 13.69M | 10.09M | 9.37M |
| Total Accrued Expenses | 27.74M | 7.79M | 7.48M | 12.23M | 11.96M |
| Short-term Debt | -- | 1.00M | 1.00M | 1.00M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 171.50K | 148.00K | 88.30K | 114.70K | 145.10K |
| Total Finance Division Other Current Liabilities | 17.65M | 18.25M | 22.65M | 28.40M | 28.40M |
| Total Other Current Liabilities | 17.65M | 18.25M | 22.65M | 28.40M | 28.40M |
| Total Current Liabilities | 55.02M | 38.21M | 44.91M | 51.84M | 49.88M |
|
|
|||||
| Total Current Liabilities | 55.02M | 38.21M | 44.91M | 51.84M | 49.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.00M | 1.00M | 1.00M | -- |
| Capital Leases | 636.70K | 681.60K | 724.90K | 767.00K | 786.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.80M | 8.04M | 7.77M | 7.51M | 7.24M |
| Total Liabilities | 63.46M | 46.92M | 53.41M | 60.12M | 57.91M |
|
|
|||||
| Common Stock & APIC | 329.80M | 326.98M | 306.35M | 295.90M | 282.71M |
| Retained Earnings | -268.26M | -247.02M | -238.80M | -230.84M | -222.06M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 61.54M | 79.96M | 67.55M | 65.06M | 60.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.54M | 79.96M | 67.55M | 65.06M | 60.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 7.54M | 13.51M | 9.98M | 2.50M | 2.92M |
| Total Equity | 69.08M | 93.47M | 77.53M | 67.56M | 63.58M |
|
|
|||||